Search results
Results from the WOW.Com Content Network
A new vaccine from Pfizer has been approved by the Food ... In extreme cases of meningitis or if the bacterial infection is left untreated, it can cause difficulty breathing, low blood pressure ...
Meningococcal vaccine refers to any vaccine used to prevent infection by Neisseria meningitidis. [9] Different versions are effective against some or all of the following types of meningococcus: A, B, C, W-135, and Y. [9] [10] The vaccines are between 85 and 100% effective for at least two years. [9]
Meningococcal meningitis is a bacterial infection caused by the Neisseria meningitidis bacterium, commonly known as meningococcus. The vaccine is created using bacterial capsular polysaccharides derived from each of the targeted serogroups through fermentation processes in bioreactors .
According to the U.S. Centers for Disease Control and Prevention, while "any vaccine can cause side effects", [11] most side effects are minor, primarily including sore arms or a mild fever. [11] Unlike most medical interventions vaccines are given to healthy people, where the risk of side effects is not as easily outweighed by the benefit of ...
In fact, vaccine developers usually strive to create a product that works as well as possible while triggering as few side effects as possible. Almost “everybody gets an immune response” after ...
"But bacterial meningitis is a serious disease and parents should be vigilant if there is an outbreak at their child's school." Wellness, parenting, body image and more: Get to know the who behind ...
Penbraya is a pentavalent conjugate vaccine developed by Pfizer for the prevention of invasive meningococcal disease in people 10 through 25 years of age. [4] Invasive meningococcal disease, caused by the bacterium Neisseria meningitidis, can lead to serious conditions such as meningitis (inflammation of the brain and spinal cord lining) and sepsis. [5]
Young people are being asked to arrange to get any vaccines they might have missed over the years.